At a glance
- Originator Unknown
- Class Anti-ischaemics; Cytoprotectives; Small molecules
- Mechanism of Action Adenosine deaminase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cerebral ischaemia; Ischaemic heart disorders
Most Recent Events
- 28 Jun 2001 No-Development-Reported for Cerebral ischaemia in USA (Unknown route)
- 28 Jun 2001 No-Development-Reported for Ischaemic heart disorders in USA (Unknown route)
- 17 Jun 1998 New profile